1-acetyl-3,2-toluyl-5-fluorouracil has been researched along with Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MH; Cheng, YN; Cui, SX; Li, X; Liu, J; Makuuchi, M; Qu, XJ; Tang, W; Tian, ZG; Xu, WF | 1 |
1 other study(ies) available for 1-acetyl-3,2-toluyl-5-fluorouracil and Carcinoma
Article | Year |
---|---|
Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Microsomes, Liver; Prodrugs; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2007 |